Sanofi posts upbeat sales as R&D pressure builds
Summary
A string of research setbacks have left the pharmaceutical giant at a crossroads just as a new CEO is set to take over. But positive first-quarter earnings prov...
Description
A string of research setbacks have left the pharmaceutical giant at a crossroads just as a new CEO is set to take over. But positive first-quarter earnings prov...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source